Administration of a single broadly neutralizing human immunodeficiency virus (HIV)–specific antibody to HIV-infected persons leads to the development of antibody-resistant virus in the absence of ...
Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...
In a recent study published in EBioMedicine, a group of researchers determined the impact of nicotinamide mononucleotide (NMN) on Clusters of differentiation 4 + (CD4 +) Thymus cells (T cells) viz. T ...
Heterosexuals with HIV have lower CD4 counts at diagnosis than their gay and bisexual male peers, according to an analysis of more than 300,000 people living with HIV globally. "It was quite a ...
A review found that CD4/CD8 ratio could be used as a prognostic marker for mortality in patients with HIV, though future studies need to be done to confirm these findings. Clinical practices can ...
A large international clinical trial has unveiled a promising new option for people living with highly treatment-resistant ...
Anna Maria Geretti receives funding for the work described from the European AIDS Treatment Network (NEAT) and the British HIV Association (BHIVA). She is affiliated with the Governing Board and is ...
In patients with HIV‑1 infection and virologic suppression, switching to an investigational regimen of doravirine plus ...
Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results